Langford J H, Benrimoj S
Department of Pharmacy, University of Sydney, New South Wales, Australia.
Ann Pharmacother. 1997 Jan;31(1):34-8. doi: 10.1177/106002809703100104.
To evaluate the antibacterial activity, onset of action, and duration of action of four topical antimicrobial gels containing cetrimide, bacitracin, polymyxin B sulfate, and a placebo gel.
Multiples (1 x, 2x, 4x, 8x) of minimally inhibitory in vitro drug concentrations were formulated in a gel vehicle. Antibacterial activity was evaluated using a scrub-wash methodology on artificially inoculated skin over an 8-hour study period.
Healthy volunteers with intact forearm skin participated in the study. A standardized culture of Staphylococcus aureus NCTC 6571 was applied to four areas on each forearm, randomly assigned topical treatments were applied, and sites were sampled at predetermined time intervals using a surfactant wash fluid.
Recovered bacteria were quantitated, allowing a comparison of antibacterial activity.
Two-way and one-way ANOVA and a Scheffe test confirmed significant differences in antibacterial effect between the formulations containing 4 and 8 times the minimally inhibitory in vitro concentrations and placebo (p < 0.05). Duration of action was similar for all preparations; however, onset appeared to be faster with the formulations containing 4 and 8 times minimally inhibitory in vitro concentrations.
The two topical preparations containing 4 and 8 times the minimally inhibitory in vitro concentrations of cetrimide, bacitracin, and polymyxin B sulfate demonstrated significant antibacterial activity and may have potential for further clinical investigations.
评估四种含有西曲溴铵、杆菌肽、硫酸多粘菌素B的局部抗菌凝胶及一种安慰剂凝胶的抗菌活性、起效时间和作用持续时间。
在凝胶载体中配制体外最小抑菌药物浓度的倍数(1倍、2倍、4倍、8倍)。在为期8小时的研究期间,采用擦洗方法在人工接种的皮肤上评估抗菌活性。
前臂皮肤完整的健康志愿者参与了该研究。将金黄色葡萄球菌NCTC 6571的标准化培养物涂于每个前臂的四个区域,随机分配局部治疗,并用表面活性剂冲洗液在预定时间间隔对部位进行采样。
对回收的细菌进行定量,以便比较抗菌活性。
双向和单向方差分析以及谢费检验证实,含有4倍和8倍体外最小抑菌浓度的制剂与安慰剂之间的抗菌效果存在显著差异(p < 0.05)。所有制剂的作用持续时间相似;然而,含有4倍和8倍体外最小抑菌浓度的制剂起效似乎更快。
含有4倍和8倍体外最小抑菌浓度西曲溴铵、杆菌肽和硫酸多粘菌素B的两种局部制剂显示出显著的抗菌活性,可能有进一步临床研究的潜力。